Olly Barker, 9, was diagnosed with an extremely rare genetic disorder aged five ...
Olly Barker, from Rishton, has SYNGAP1 - an extremely rare genetic disorder which affects brain development and can cause ...
Each month Your Child’s Brain will bring together experts in child brain health, including researchers, educators, physicians and therapists as well as families to discuss contemporary topics about ...
Julie M. Orlando, PT, PhD, and Jillian McKee, MD, PhD, co-principal investigators on CURE SYNGAP1’s “Validating Remote Developmental Assessments in SYNGAP1-Related Disorders” grant, which aims to ...
CAMP4 Therapeutics Corporation has an analyst consensus of Strong Buy, with a price target consensus of $8.36, implying a 99.05% upside from current levels. In a report released on June 10, Chardan ...
Buy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028 ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results